Sphingosine kinase: A promising cancer therapeutic target

Commentary to: Antitumor activity of Sphingosine Kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts Vladimir Beljanski, Clayton S. Lewis and Charles D. Smith

Saved in:
Bibliographic Details
Published in:Cancer biology & therapy 2011-04, Vol.11 (7), p.647-650
Main Authors: Antoon, James W., Beckman, Barbara S.
Format: Article
Language:English
Subjects:
Animals
Antineoplastic Agents - therapeutic use
Binding
Biology
Bioscience
Calcium
Cancer
Cell
Cycle
Enzyme Inhibitors - therapeutic use
Humans
Landes
Molecular Targeted Therapy
Neoplasms - drug therapy
Neoplasms - metabolism
Organogenesis
Phosphotransferases (Alcohol Group Acceptor) - metabolism
Proteins
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c471t-c08436ff890f5d24972d1ed129a1eb2305e6fb6163d646f8f2af8b8c1501ad63
cites
container_end_page 650
container_issue 7
container_start_page 647
container_title Cancer biology & therapy
container_volume 11
creator Antoon, James W.
Beckman, Barbara S.
description Commentary to: Antitumor activity of Sphingosine Kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts Vladimir Beljanski, Clayton S. Lewis and Charles D. Smith
doi_str_mv 10.4161/cbt.11.7.14921
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_4161_cbt_11_7_14921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>860178477</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-c08436ff890f5d24972d1ed129a1eb2305e6fb6163d646f8f2af8b8c1501ad63</originalsourceid><addsrcrecordid>eNqFkc-P1CAYhonRuOvq1aPpzVMrH6VAvY0TfyWbeHDuhMLHLNopFZiY_e9ldta5GU8Q8rwvHw-EvAbacRDwzk6lA-hkB3xk8IRcwzAMrRqkeHra96rllMsr8iLnH5QyycT4nFwx6KkUnF6T8ft6F5Z9zGHB5mdYTMb3zaZZUzyEerZvrFkspqbcYTIrHkuwTTFpj-UleebNnPHV43pDdp8-7rZf2ttvn79uN7et5RJKa6nivfBejdQPjvFRMgfogI0GcGI9HVD4SYDoneDCK8-MV5OyMFAwTvQ35O25to7064i56DqYxXk2C8Zj1kpQkIpLWcnuTNoUc07o9ZrCwaR7DVSfZOkqSwNoqR9k1cCbx-rjdEB3wf_aqQCcgXqZwzyFmG3A6uOCnhpNqlJmvJTy_2So3CwlxoVtP-weplmdr7HxHAuLj-lgfsc0O13M_RyTT_UPQtb9P97xB1_AnSk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>860178477</pqid></control><display><type>article</type><title>Sphingosine kinase: A promising cancer therapeutic target</title><source>Open Access: PubMed Central</source><source>Elektronische Zeitschriftenbibliothek</source><creator>Antoon, James W. ; Beckman, Barbara S.</creator><creatorcontrib>Antoon, James W. ; Beckman, Barbara S.</creatorcontrib><description>Commentary to: Antitumor activity of Sphingosine Kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts Vladimir Beljanski, Clayton S. Lewis and Charles D. Smith</description><identifier>ISSN: 1538-4047</identifier><identifier>EISSN: 1555-8576</identifier><identifier>DOI: 10.4161/cbt.11.7.14921</identifier><identifier>PMID: 21307640</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Animals ; Antineoplastic Agents - therapeutic use ; Binding ; Biology ; Bioscience ; Calcium ; Cancer ; Cell ; Cycle ; Enzyme Inhibitors - therapeutic use ; Humans ; Landes ; Molecular Targeted Therapy ; Neoplasms - drug therapy ; Neoplasms - metabolism ; Organogenesis ; Phosphotransferases (Alcohol Group Acceptor) - metabolism ; Proteins</subject><ispartof>Cancer biology &amp; therapy, 2011-04, Vol.11 (7), p.647-650</ispartof><rights>Copyright © 2011 Landes Bioscience 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-c08436ff890f5d24972d1ed129a1eb2305e6fb6163d646f8f2af8b8c1501ad63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27898,27899</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21307640$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Antoon, James W.</creatorcontrib><creatorcontrib>Beckman, Barbara S.</creatorcontrib><title>Sphingosine kinase: A promising cancer therapeutic target</title><title>Cancer biology &amp; therapy</title><addtitle>Cancer Biol Ther</addtitle><description>Commentary to: Antitumor activity of Sphingosine Kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts Vladimir Beljanski, Clayton S. Lewis and Charles D. Smith</description><subject>Animals</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Binding</subject><subject>Biology</subject><subject>Bioscience</subject><subject>Calcium</subject><subject>Cancer</subject><subject>Cell</subject><subject>Cycle</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Humans</subject><subject>Landes</subject><subject>Molecular Targeted Therapy</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - metabolism</subject><subject>Organogenesis</subject><subject>Phosphotransferases (Alcohol Group Acceptor) - metabolism</subject><subject>Proteins</subject><issn>1538-4047</issn><issn>1555-8576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkc-P1CAYhonRuOvq1aPpzVMrH6VAvY0TfyWbeHDuhMLHLNopFZiY_e9ldta5GU8Q8rwvHw-EvAbacRDwzk6lA-hkB3xk8IRcwzAMrRqkeHra96rllMsr8iLnH5QyycT4nFwx6KkUnF6T8ft6F5Z9zGHB5mdYTMb3zaZZUzyEerZvrFkspqbcYTIrHkuwTTFpj-UleebNnPHV43pDdp8-7rZf2ttvn79uN7et5RJKa6nivfBejdQPjvFRMgfogI0GcGI9HVD4SYDoneDCK8-MV5OyMFAwTvQ35O25to7064i56DqYxXk2C8Zj1kpQkIpLWcnuTNoUc07o9ZrCwaR7DVSfZOkqSwNoqR9k1cCbx-rjdEB3wf_aqQCcgXqZwzyFmG3A6uOCnhpNqlJmvJTy_2So3CwlxoVtP-weplmdr7HxHAuLj-lgfsc0O13M_RyTT_UPQtb9P97xB1_AnSk</recordid><startdate>20110401</startdate><enddate>20110401</enddate><creator>Antoon, James W.</creator><creator>Beckman, Barbara S.</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110401</creationdate><title>Sphingosine kinase: A promising cancer therapeutic target</title><author>Antoon, James W. ; Beckman, Barbara S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-c08436ff890f5d24972d1ed129a1eb2305e6fb6163d646f8f2af8b8c1501ad63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Binding</topic><topic>Biology</topic><topic>Bioscience</topic><topic>Calcium</topic><topic>Cancer</topic><topic>Cell</topic><topic>Cycle</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Humans</topic><topic>Landes</topic><topic>Molecular Targeted Therapy</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - metabolism</topic><topic>Organogenesis</topic><topic>Phosphotransferases (Alcohol Group Acceptor) - metabolism</topic><topic>Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Antoon, James W.</creatorcontrib><creatorcontrib>Beckman, Barbara S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer biology &amp; therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Antoon, James W.</au><au>Beckman, Barbara S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sphingosine kinase: A promising cancer therapeutic target</atitle><jtitle>Cancer biology &amp; therapy</jtitle><addtitle>Cancer Biol Ther</addtitle><date>2011-04-01</date><risdate>2011</risdate><volume>11</volume><issue>7</issue><spage>647</spage><epage>650</epage><pages>647-650</pages><issn>1538-4047</issn><eissn>1555-8576</eissn><abstract>Commentary to: Antitumor activity of Sphingosine Kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts Vladimir Beljanski, Clayton S. Lewis and Charles D. Smith</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>21307640</pmid><doi>10.4161/cbt.11.7.14921</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1538-4047
ispartof Cancer biology & therapy, 2011-04, Vol.11 (7), p.647-650
issn 1538-4047
1555-8576
language eng
recordid cdi_crossref_primary_10_4161_cbt_11_7_14921
source Open Access: PubMed Central; Elektronische Zeitschriftenbibliothek
subjects Animals
Antineoplastic Agents - therapeutic use
Binding
Biology
Bioscience
Calcium
Cancer
Cell
Cycle
Enzyme Inhibitors - therapeutic use
Humans
Landes
Molecular Targeted Therapy
Neoplasms - drug therapy
Neoplasms - metabolism
Organogenesis
Phosphotransferases (Alcohol Group Acceptor) - metabolism
Proteins
title Sphingosine kinase: A promising cancer therapeutic target
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-04T23%3A19%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sphingosine%20kinase:%20A%20promising%20cancer%20therapeutic%20target&rft.jtitle=Cancer%20biology%20&%20therapy&rft.au=Antoon,%20James%20W.&rft.date=2011-04-01&rft.volume=11&rft.issue=7&rft.spage=647&rft.epage=650&rft.pages=647-650&rft.issn=1538-4047&rft.eissn=1555-8576&rft_id=info:doi/10.4161/cbt.11.7.14921&rft_dat=%3Cproquest_cross%3E860178477%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c471t-c08436ff890f5d24972d1ed129a1eb2305e6fb6163d646f8f2af8b8c1501ad63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=860178477&rft_id=info:pmid/21307640&rfr_iscdi=true